Annual FCF:
$13.80B+$2.10B(+17.94%)Summary
- As of April 3, 2025, NVS annual free cash flow is $13.80 billion, with the most recent change of +$2.10 billion (+17.94%) on December 31, 2024.
- During the last 3 years, NVS annual FCF has risen by +$1.29 billion (+10.31%).
- NVS annual FCF is now at all-time high.
Performance
NVS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF:
$3.06B-$2.42B(-44.20%)Summary
- As of April 3, 2025, NVS quarterly free cash flow is $3.06 billion, with the most recent change of -$2.42 billion (-44.20%) on December 31, 2024.
- Over the past year, NVS quarterly FCF has stayed the same.
- NVS quarterly FCF is now -67.90% below its all-time high of $9.54 billion, reached on September 30, 2007.
Performance
NVS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF:
$13.80B+$1.30B(+10.38%)Summary
- As of April 3, 2025, NVS TTM free cash flow is $13.80 billion, with the most recent change of +$1.30 billion (+10.38%) on December 31, 2024.
- Over the past year, NVS TTM FCF has stayed the same.
- NVS TTM FCF is now at all-time high.
Performance
NVS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NVS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.9% | 0.0% | 0.0% |
| 3 y3 years | +10.3% | 0.0% | 0.0% |
| 5 y5 years | +21.4% | 0.0% | 0.0% |
NVS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.9% | -44.2% | +287.6% | at high | +34.7% |
| 5 y | 5-year | at high | +24.8% | -44.2% | +287.6% | at high | +34.7% |
| alltime | all time | at high | +363.7% | -67.9% | +148.2% | at high | +1013.6% |
Novartis AG Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $13.80B(+17.9%) | $3.06B(-44.2%) | $13.80B(+10.4%) |
| Sep 2024 | - | $5.49B(+32.3%) | $12.51B(+6.8%) |
| Jun 2024 | - | $4.15B(+273.9%) | $11.71B(+14.3%) |
| Mar 2024 | - | $1.11B(-37.1%) | $10.25B(-12.5%) |
| Dec 2023 | $11.71B(-2.4%) | $1.76B(-62.4%) | $11.71B(-13.6%) |
| Sep 2023 | - | $4.70B(+75.3%) | $13.55B(+2.1%) |
| Jun 2023 | - | $2.68B(+4.3%) | $13.28B(-3.6%) |
| Mar 2023 | - | $2.57B(-28.9%) | $13.78B(+14.8%) |
| Dec 2022 | $12.00B(-4.1%) | $3.61B(-18.3%) | $12.00B(+2.5%) |
| Sep 2022 | - | $4.42B(+39.4%) | $11.71B(+0.3%) |
| Jun 2022 | - | $3.17B(+301.5%) | $11.67B(-3.0%) |
| Mar 2022 | - | $790.00M(-76.2%) | $12.03B(-3.9%) |
| Dec 2021 | $12.52B(+13.1%) | $3.32B(-24.3%) | $12.52B(+2.8%) |
| Sep 2021 | - | $4.39B(+24.1%) | $12.18B(+18.0%) |
| Jun 2021 | - | $3.54B(+177.9%) | $10.32B(+0.3%) |
| Mar 2021 | - | $1.27B(-57.3%) | $10.29B(-7.0%) |
| Dec 2020 | $11.06B(-2.7%) | $2.98B(+17.9%) | $11.06B(+0.7%) |
| Sep 2020 | - | $2.53B(-27.9%) | $10.99B(-11.8%) |
| Jun 2020 | - | $3.51B(+71.6%) | $12.46B(+7.2%) |
| Mar 2020 | - | $2.04B(-29.6%) | $11.62B(+2.2%) |
| Dec 2019 | $11.37B(-2.2%) | $2.90B(-27.4%) | $11.37B(-1.8%) |
| Sep 2019 | - | $4.00B(+49.8%) | $11.58B(+7.3%) |
| Jun 2019 | - | $2.67B(+49.0%) | $10.79B(-6.8%) |
| Mar 2019 | - | $1.79B(-42.5%) | $11.58B(-0.4%) |
| Dec 2018 | $11.62B(+12.6%) | $3.12B(-2.9%) | $11.62B(+2.0%) |
| Sep 2018 | - | $3.21B(-7.2%) | $11.40B(+2.6%) |
| Jun 2018 | - | $3.46B(+88.0%) | $11.11B(+4.0%) |
| Mar 2018 | - | $1.84B(-36.3%) | $10.68B(+3.4%) |
| Dec 2017 | $10.33B(+20.1%) | $2.89B(-0.9%) | $10.33B(+0.8%) |
| Sep 2017 | - | $2.92B(-3.7%) | $10.25B(+4.1%) |
| Jun 2017 | - | $3.03B(+103.2%) | $9.85B(+6.4%) |
| Mar 2017 | - | $1.49B(-46.9%) | $9.25B(+7.7%) |
| Dec 2016 | $8.60B(+2.4%) | $2.81B(+11.6%) | $8.60B(-4.2%) |
| Sep 2016 | - | $2.52B(+3.3%) | $8.97B(+1.9%) |
| Jun 2016 | - | $2.44B(+192.4%) | $8.80B(+6.9%) |
| Mar 2016 | - | $833.00M(-73.9%) | $8.24B(-1.9%) |
| Dec 2015 | $8.39B(-20.0%) | $3.19B(+35.9%) | $8.39B(-12.3%) |
| Sep 2015 | - | $2.35B(+25.6%) | $9.57B(-6.5%) |
| Jun 2015 | - | $1.87B(+88.9%) | $10.24B(-4.7%) |
| Mar 2015 | - | $989.00M(-77.4%) | $10.75B(+2.4%) |
| Dec 2014 | $10.49B(+7.1%) | $4.37B(+45.1%) | $10.49B(+10.5%) |
| Sep 2014 | - | $3.01B(+26.7%) | $9.50B(-4.9%) |
| Jun 2014 | - | $2.38B(+224.4%) | $9.98B(+6.8%) |
| Mar 2014 | - | $733.00M(-78.3%) | $9.35B(-4.5%) |
| Dec 2013 | $9.80B | $3.37B(-3.6%) | $9.80B(-5.5%) |
| Sep 2013 | - | $3.50B(+100.7%) | $10.37B(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | $1.74B(+48.0%) | $10.18B(-4.9%) |
| Mar 2013 | - | $1.18B(-70.2%) | $10.71B(-6.3%) |
| Dec 2012 | $11.42B(-4.2%) | $3.95B(+19.2%) | $11.42B(-0.9%) |
| Sep 2012 | - | $3.31B(+45.8%) | $11.52B(-2.9%) |
| Jun 2012 | - | $2.27B(+20.0%) | $11.86B(-4.4%) |
| Mar 2012 | - | $1.89B(-53.3%) | $12.41B(+4.1%) |
| Dec 2011 | $11.92B(+0.7%) | $4.05B(+10.9%) | $11.92B(+1.8%) |
| Sep 2011 | - | $3.65B(+29.3%) | $11.71B(+7.5%) |
| Jun 2011 | - | $2.82B(+101.4%) | $10.89B(+5.0%) |
| Mar 2011 | - | $1.40B(-63.4%) | $10.38B(-12.3%) |
| Dec 2010 | $11.84B(+25.1%) | $3.83B(+35.2%) | $11.84B(+3.1%) |
| Sep 2010 | - | $2.83B(+22.8%) | $11.47B(+1.7%) |
| Jun 2010 | - | $2.31B(-19.3%) | $11.28B(+3.8%) |
| Mar 2010 | - | $2.86B(-17.7%) | $10.87B(+14.9%) |
| Dec 2009 | $9.46B(+26.9%) | $3.47B(+31.6%) | $9.46B(+10.0%) |
| Sep 2009 | - | $2.64B(+38.9%) | $8.60B(+2.4%) |
| Jun 2009 | - | $1.90B(+31.1%) | $8.39B(+10.9%) |
| Mar 2009 | - | $1.45B(-44.5%) | $7.57B(+1.5%) |
| Dec 2008 | $7.45B(+22.6%) | $2.61B(+7.1%) | $7.45B(-593.2%) |
| Sep 2008 | - | $2.44B(+127.5%) | -$1.51B(-127.0%) |
| Jun 2008 | - | $1.07B(-19.9%) | $5.59B(-3.5%) |
| Mar 2008 | - | $1.34B(-121.0%) | $5.80B(-4.6%) |
| Dec 2007 | $6.08B(+0.0%) | -$6.36B(-166.6%) | $6.08B(-53.9%) |
| Sep 2007 | - | $9.54B(+648.8%) | $13.19B(+134.1%) |
| Jun 2007 | - | $1.27B(-21.3%) | $5.63B(-0.2%) |
| Mar 2007 | - | $1.62B(+114.9%) | $5.64B(-7.1%) |
| Dec 2006 | $6.07B(-4.6%) | $753.00M(-62.1%) | $6.07B(-8.6%) |
| Sep 2006 | - | $1.99B(+54.9%) | $6.65B(-3.8%) |
| Jun 2006 | - | $1.28B(-37.4%) | $6.91B(+3.3%) |
| Mar 2006 | - | $2.05B(+54.7%) | $6.68B(+4.9%) |
| Dec 2005 | $6.37B(+24.3%) | $1.32B(-41.1%) | $6.37B(+3.0%) |
| Sep 2005 | - | $2.25B(+111.7%) | $6.19B(+8.9%) |
| Jun 2005 | - | $1.06B(-38.8%) | $5.68B(-4.7%) |
| Mar 2005 | - | $1.74B(+51.9%) | $5.96B(+16.2%) |
| Dec 2004 | $5.13B(+2.3%) | $1.14B(-34.4%) | $5.13B(+1.4%) |
| Sep 2004 | - | $1.74B(+29.9%) | $5.05B(+3.5%) |
| Jun 2004 | - | $1.34B(+48.4%) | $4.88B(+11.6%) |
| Mar 2004 | - | $903.00M(-15.5%) | $4.37B(-12.7%) |
| Dec 2003 | $5.01B(+23.1%) | $1.07B(-31.8%) | $5.01B(+27.1%) |
| Sep 2003 | - | $1.57B(+87.9%) | $3.94B(+66.0%) |
| Jun 2003 | - | $834.00M(-45.8%) | $2.37B(+54.2%) |
| Mar 2003 | - | $1.54B | $1.54B |
| Dec 2002 | $4.07B(+36.7%) | - | - |
| Dec 2001 | $2.98B(-23.2%) | - | - |
| Dec 2000 | $3.88B(+11.9%) | - | - |
| Dec 1999 | $3.47B(+11.6%) | - | - |
| Dec 1998 | $3.11B | - | - |
FAQ
- What is Novartis AG annual free cash flow?
- What is the all time high annual FCF for Novartis AG?
- What is Novartis AG annual FCF year-on-year change?
- What is Novartis AG quarterly free cash flow?
- What is the all time high quarterly FCF for Novartis AG?
- What is Novartis AG quarterly FCF year-on-year change?
- What is Novartis AG TTM free cash flow?
- What is the all time high TTM FCF for Novartis AG?
- What is Novartis AG TTM FCF year-on-year change?
What is Novartis AG annual free cash flow?
The current annual FCF of NVS is $13.80B
What is the all time high annual FCF for Novartis AG?
Novartis AG all-time high annual free cash flow is $13.80B
What is Novartis AG annual FCF year-on-year change?
Over the past year, NVS annual free cash flow has changed by +$2.10B (+17.94%)
What is Novartis AG quarterly free cash flow?
The current quarterly FCF of NVS is $3.06B
What is the all time high quarterly FCF for Novartis AG?
Novartis AG all-time high quarterly free cash flow is $9.54B
What is Novartis AG quarterly FCF year-on-year change?
Over the past year, NVS quarterly free cash flow has changed by $0.00 (0.00%)
What is Novartis AG TTM free cash flow?
The current TTM FCF of NVS is $13.80B
What is the all time high TTM FCF for Novartis AG?
Novartis AG all-time high TTM free cash flow is $13.80B
What is Novartis AG TTM FCF year-on-year change?
Over the past year, NVS TTM free cash flow has changed by $0.00 (0.00%)